ea0094oc3.1 | Neuroendocrinology and Pituitary | SFEBES2023
Rai Ashutosh
, Begalli Federica
, Barry Sayka
, Rice Thomas
, Magid Kesson
, Suleyman Oniz
, Dorward Neil
, Grieve Joan
, Kolias Angelos
, Khan Danyal
, J Marcus Hani J.
, Radotra Bishan D.
, Chhabra Rajesh
, Dhandapani S S.
, Tripathi Manjul
, Ahuja Chirag K.
, Dutta Pinaki
, Korbonits Marta
Background: There is no effective medical treatment available for non-functioning pituitary neuroendocrine tumours (NF-PitNETs). Recurrence (7-12%) or incomplete resection (30-45%) is a common feature. Thus, finding novel medical therapies to help the management of these tumours would be of great value. By using high-throughput mass spectrometry combined with functional characterisation, we explored novel therapeutic targets for NF-PitNETs.<p class="abstex...